▶ 調査レポート

行動リハビリテーションの世界市場:製品別(モノクローナル抗体、ワクチン、組換えホルモン・タンパク質、細胞療法、遺伝子治療、その他)、用途別(がん、感染症、希少疾患、自己免疫疾患、その他)、地域別分析

• 英文タイトル:Global Behavioral Rehabilitation Market - Segmented by Type of Behavioral Rehabilitation, Healthcare Setting and Treatment - Growth, Trends and Forecasts (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。行動リハビリテーションの世界市場:製品別(モノクローナル抗体、ワクチン、組換えホルモン・タンパク質、細胞療法、遺伝子治療、その他)、用途別(がん、感染症、希少疾患、自己免疫疾患、その他)、地域別分析 / Global Behavioral Rehabilitation Market - Segmented by Type of Behavioral Rehabilitation, Healthcare Setting and Treatment - Growth, Trends and Forecasts (2018 - 2023) / B-MOR-040401資料のイメージです。• レポートコード:B-MOR-040401
• 出版社/出版日:Mordor Intelligence / 2018年3月
• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User(1名様用)¥629,000 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥666,000 (USD4,500)▷ お問い合わせ
  Corporate User¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、行動リハビリテーションの世界市場について調べ、行動リハビリテーションの世界規模、市場動向、市場環境、製品別(モノクローナル抗体、ワクチン、組換えホルモン・タンパク質、細胞療法、遺伝子治療、その他)分析、用途別(がん、感染症、希少疾患、自己免疫疾患、その他)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・行動リハビリテーションの世界市場インサイト
・行動リハビリテーションの世界市場環境
・行動リハビリテーションの世界市場動向
・行動リハビリテーションの世界市場規模
・行動リハビリテーションの世界市場規模:製品別(モノクローナル抗体、ワクチン、組換えホルモン・タンパク質、細胞療法、遺伝子治療、その他)
・行動リハビリテーションの世界市場規模:用途別(がん、感染症、希少疾患、自己免疫疾患、その他)
・行動リハビリテーションの世界市場:地域別市場規模・分析
・行動リハビリテーションの北米市場規模・予測
・行動リハビリテーションのアメリカ市場規模・予測
・行動リハビリテーションのヨーロッパ市場規模・予測
・行動リハビリテーションのアジア市場規模・予測
・行動リハビリテーションの日本市場規模・予測
・行動リハビリテーションの中国市場規模・予測
・行動リハビリテーションのインド市場規模・予測
・行動リハビリテーションの韓国市場規模・予測
・関連企業情報・競争状況

The behavioral rehabilitation market is expected to witness a CAGR of 7% during the forecast period. North America dominates the global market due to the high incidence of behavioral disorders in the United States.

Growing Prevalence of Behavioral Disorders

According to the U.S. Department of Health and Human Services (DHHS), it is estimated that one in every five (20%) children and adolescents has a mental health disorder at some point in their life from childhood to adolescence. At least, one in 10, or about 6 million people have a serious emotional disturbance at some point in their life. Estimating the prevalence of behavioral rehabilitation disorders in children is critical, as it helps in providing mental health treatments they need. Several internet interventions have been developed for the treatment of common mental disorders. They help in remote monitoring of the patient, and thus are easily accessible by them. Also, these online counseling sessions are cost-effective.
Additionally, increasing availability of therapies for behavioral rehabilitation, increasing preferences of partial hospitalization programs (PHP) and rising government initiatives for behavioral disorders helps in the growth of the market.

Lack of Awareness of Behavioral Disorders

According to Mental Health America, 26.2% of the American population is suffering from a diagnosable mental health or addiction disorder, which is equal to 59 million Americans. However, 52% of Americans are not seeking any help for mental problems. This lack of proper awareness of behavioral disorder is restraining the growth of behavioral rehabilitation market. Many people with serious behavioral rehabilitation are facing challenges such as the struggle with the symptoms disorders, and on the other hand, they are challenged by stereotypes and prejudice that are a result of misconceptions about these behavioral disorders. Thus, the impact of stigma on people with behavioral disorders is restraining the behavioral rehabilitation market.
Additionally, lack of proper reimbursement is also restraining the growth of behavioral rehabilitation market, globally.

North America is Dominating the Market

North America is dominating behavioral rehabilitation market as rising incidences of mental disorders and availability of treatment, which are driving factors responsible for the high market share. Also, government initiatives are driving the growth of the market. The Affordable Care Act categorizes behavioral disorders as essential healthcare, which helps in covering major parts of the treatment.

Key Developments in the Market

• December 2017: Universal Health Services Inc. announces the acquisition of Memorial Behavioral Health (MBH), which provides health facility for adults, adolescents and children.

Major Players: ACADIA HEALTHCARE, UNIVERSAL HEALTH SERVICES INC., MAGELLAN HEALTH INC., PSYCHIATRIC SOLUTIONS INC., CRC HEALTH, AURORA BEHAVIORAL HEALTH SYSTEM, BEHAVIORAL HEALTH GROUP, HAVEN BEHAVIORAL HEALTHCARE INC., SPRINGSTONE, INC., AND AMERICAN ADDICTION CENTERS INC. amongst others.

Reasons to Purchase this Report

• Current and future behavioral rehabilitation market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet (in excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product & Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Growing Capital Investment from Key Market Players
6.1.2 Rise in the Prevalence of Chronic Diseases
6.1.3 Loss of Patent Exclusivity of the Leading Biologics Drugs
6.1.4 Growing Demand and Higher Acceptability for Innovative Therapies
6.2 Market Restraints
6.2.1 Stringent Regulatory Process and Initial High Capital Investment
6.2.2 Rising Control and Cost for Accessing Biologics
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Monoclonal Antibodies
7.1.2 Vaccines
7.1.3 Recombinant Hormones/Proteins
7.1.4 Cell Therapy
7.1.5 Gene Therapy
7.1.6 Others
7.2 By Application
7.2.1 Cancer
7.2.2 Infectious Diseases
7.2.3 Rare Diseases
7.2.4 Autoimmune Diseases
7.2.5 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbvie Inc.
9.2 Amgen
9.3 Eli Lilly and Company
9.4 F. Hoffmann-La Roche Ltd
9.5 Glaxosmithkline Plc.
9.6 Johnson & Johnson
9.7 Merck & Co
9.8 Novo Nordisk
9.9 Pfizer Inc.
9.10 Sanofi
9.11 Others
10. Future of the Market